3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Polycythemia Vera
4
Myeloproliferative Disorders
3
Thymic aplasia
1
Thrombosis
1
Smoking
1
Sarcoma
1
Primary Dysautonomias
1
Polycythemia
1
Polycystic Ovary Syndrome
1
Metabolic Syndrome
1
Meningeal Neoplasms
1
Meningeal Carcinomatosis
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Insulin Resistance
1
Immunologic Deficiency Syndromes
1
Hyperandrogenism
1
Histiocytoma, Malignant Fibrous
1
Colorectal Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
apixaban
5
Enoxaparin
4
Dalteparin
4
Warfarin
2
Rivaroxaban
2
Injections
2
Heparin, Low-Molecular-Weight
2
Aspirin
2
salicylhydroxamic acid
1
palbociclib
1
fluorescein isothiocyanate-keyhole limpet hemocyanin
1
enoxaparin sodium
1
edoxaban
1
bemiparin
1
X-Rays
1
Tinzaparin
1
Technetium Tc 99m Sulfur Colloid
1
Simvastatin
1
Saline Solution
1
Radiotherapy, Conformal
1
Physical Therapy Modalities
1
Photons
1
Phlebotomy
1
Paclitaxel
1
Observation
1
Musculoskeletal Manipulations
1
Hydroxyurea
1
Heparin
1
Fondaparinux
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Thrombosis
×
Phlebotomy
×
Clear all
NCT01645124
2012-07-20
CYTO-PV
Consorzio Mario Negri Sud
Phase 3
Terminated
365 enrolled